The TRHC Board
Tabula Rasa is led by a diverse yet cohesive board of directors who share a commitment to improving lives and advancing the goals and objectives of our companies. The Board is comprised of members drawn from careers in business, healthcare, finance, academia, and public service. They determine our strategies and policies, and are dedicated to serving the interests of our company and our shareholders.
Independent Board Chairman
Tabula Rasa HealthCare
Michael Purcell was audit partner at Deloitte & Touche for 36 years, serving as the Philadelphia Office leader for middle-market and growth enterprises. He has assisted many emerging companies, including successful initial public offerings and exit transactions. He currently serves as a consultant for several venture funds. Mr. Purcell has served on the Board of Directors and Audit Committees of numerous for-profit entities, including Capital Funding Bancorp, McKean Defense Group, Code 3 Emergency Partners, and Intermex.
Samira K. Beckwith
President and CEO
Samira K. Beckwith is President and CEO of Hope Healthcare. She serves on the Board of Directors of the Florida Center for Nursing. Dr. Beckwith was appointed to the White House Conference on Aging and the US Senate Special Committee on Aging. She also was Chair of the National Hospice and Palliative Care Organization and the National Hospice Foundation. Dr. Beckwith is the Founding President of the Florida PACE Association and a Founding Director of the National Hospice Work Group.
Jan Berger, MD, MJ
Founder, President, and CEO
Health Intelligence Partners
Jan Berger, MD, MJ, is Founder, President and CEO of Health Intelligence Partners, a global healthcare consultancy. Previously, she was Senior Vice President, Chief Clinical Officer and Innovation Officer, CVS Health/Caremark, and Chief Clinical Strategist for Quantum Health. Dr. Berger currently serves on the Board of Directors of Cambia Health Solutions, Accentcare, Inc. and GNS Healthcare. She is an Assistant Professor at Northwestern University’s School of Medicine and School of Communication.
Dennis K. Helling, PharmD, ScD
Executive Director Emeritus, Pharmacy
Kaiser Permanente, Colorado
Dennis K. Helling, PharmD, ScD (Hon), FCCP, FASHP, FAPhA is Executive Director Emeritus, Pharmacy Operations & Therapeutics, Kaiser Permanente Colorado, and retired Clinical Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. He served as President of American College of Clinical Pharmacy, the Accreditation Council for Pharmacy Education and the American Pharmacists Association (APhA) Foundation. He is on the Boards of Care Synergy and Denver Hospice. Dr. Helling received the 2013 Remington Honor Medal, Pharmacy’s Highest Award.
CEO and Co-Founder of Humanity Health
Ron Mitchell is CEO and Co-Founder of Humanity Health, a leading executive recruitment and development platform for the healthcare and life sciences industry. Previously, Ron was CEO of Virgil Holdings Inc., an enterprise SaaS company that owns and operates Hcareers and Virgil Careers. He has more than 20 years of experience building technology-enabled enterprise businesses, providing him with a keen understanding of the challenges that managers face in strategic execution, mergers and acquisitions, and team leadership.
Vice President/General Manager, Skin & Marketing Services
Kathy O’Brien is Vice President of Skin and Marketing Services, Unilever North America, overseeing a portfolio of brands including Dove, Caress, Suave, and Vaseline. Previously, she was Unilever’s Vice President and General Manager of Foods in the U.S. Ms. O’Brien was named a “Top Woman in Grocery” by Progressive Grocer Magazine and Advertising Age’s “25 Women to Watch”. She is a Board Director of Network of Executive Women, Cosmetic Executive Women, and a Trustee of Lehigh Valley Health Network.
Managing Director and Chief Investment Officer
Indaba Capital Management, LP
Prior to founding Indaba Capital Management, LP, in 2010, Derek Schrier was a partner at Farallon Capital Management, L.L.C. He has also worked at Goldman Sachs & Co., as well as for the anti-apartheid movement in South Africa, ultimately managing the elections research for the African National Congress’s political campaign during that country’s first-ever democratic and non-racial elections.
Interim General Counsel
Jonathan Schwartz is the Interim General Counsel of the The Brookings Institution. He previously served as the general counsel at Napster Inc., Cablevision Systems Corp., JPMorgan’s Investment Bank, and at Univision Communication Inc. Mr. Schwartz also was on the board of directors of Revlon, Inc. Earlier in his career Mr. Schwartz served as U.S. Supreme Court law clerk, as a federal prosecutor, and as a senior official at the Department of Justice.
Rear Admiral Pamela Schweitzer, PharmD (retired)
Chief Pharmacy Officer
United States Public Health Services
Rear Admiral (RADM) Pamela Schweitzer was Assistant Surgeon General and Chief Pharmacy Officer of the United States Public Health Service (PHS), responsible for providing leadership and coordination of PHS pharmacy programs and professional affairs. She served with the Centers for Medicare and Medicaid Services (CMS), Indian Health Service (IHS) and Veterans Administration (VA). RADM Schweitzer has received numerous honors, including American Pharmacists Association Distinguished Federal Pharmacist Award, USPHS Mary Louise Anderson Leadership Award, and IHS Senior Pharmacist of the Year.